Emerging Infectious Diseases (Oct 2007)

Personal Protective Equipment and Antiviral Drug Use during Hospitalization for Suspected Avian or Pandemic Influenza

  • Ashwin Swaminathan,
  • Rhea Martin,
  • Sandi Gamon,
  • Craig Aboltins,
  • Eugene Athan,
  • George Braitberg,
  • Michael G. Catton,
  • Louise Cooley,
  • Dominic E. Dwyer,
  • Deidre Edmonds,
  • Damon P. Eisen,
  • Kelly Hosking,
  • Andrew J. Hughes,
  • Paul D. Johnson,
  • Andrew V Maclean,
  • Mary O’Reilly,
  • S. Erica Peters,
  • Rhonda L. Stuart,
  • Rodney Moran,
  • M. Lindsay Grayson

DOI
https://doi.org/10.3201/eid1310.070033
Journal volume & issue
Vol. 13, no. 10
pp. 1541 – 1547

Abstract

Read online

For pandemic influenza planning, realistic estimates of personal protective equipment (PPE) and antiviral medication required for hospital healthcare workers (HCWs) are vital. In this simulation study, a patient with suspected avian or pandemic influenza (API) sought treatment at 9 Australian hospital emergency departments where patient–staff interactions during the first 6 hours of hospitalization were observed. Based on World Health Organization definitions and guidelines, the mean number of “close contacts” of the API patient was 12.3 (range 6–17; 85% HCWs); mean “exposures” were 19.3 (range 15–26). Overall, 20–25 PPE sets were required per patient, with variable HCW compliance for wearing these items (93% N95 masks, 77% gowns, 83% gloves, and 73% eye protection). Up to 41% of HCW close contacts would have qualified for postexposure antiviral prophylaxis. These data indicate that many current national stockpiles of PPE and antiviral medication are likely inadequate for a pandemic.

Keywords